Drug Warning: Mobic
Generic name: meloxicam (class of drugs known as NSAIDs)
Manufactured and marketed by: Abbott Laboratories
Purpose: Prescribed to patients suffering from the symptoms of rheumatoid arthritis and osteoarthritis, which may include swelling, inflammation, stiffness, and joint pain.
Side Effects Reported
- NSAIDs have been linked to liver damage.
- Patients taking NSAIDs, including Mobic, should be aware of the symptoms of liver damage which include yellow coloring of the skin or eyes, dark urine, fatigue, nausea, vomiting, loss of appetite, and flu like symptoms.
NSAIDs may also be linked to cardiovascular problems including heart attack and stroke. In addition, NSAIDs may be associated with an increased risk of hypertension, congestive heart failure, and edema. NSAIDs as a class are also linked to gastrointestinal problems including bleeding and ulceration.
Seeger Weiss is not currently pursuing lawsuits on this drug, but its drug warnings will remain on our radar.Free Case Evaluation
Chevrolet’s so-called “clean diesel” models Cruze and Colorado emit higher levels of pollution than originally disclosed to the government, and more than the company claimed was emitted in its marketing [...]September 2, 2016 By: Seeger Weiss read more
For some time, Janssen Pharmaceutical’s diabetes medication Invokana has been known to trigger serious side effects, including ketoacidosis, in users. Ketoacidosis occurs when there is a presence of abnormally high ketones in [...]August 31, 2016 By: Seeger Weiss read more